Sivik Global Healthcare as of Dec. 31, 2019
Portfolio Holdings for Sivik Global Healthcare
Sivik Global Healthcare holds 50 positions in its portfolio as reported in the December 2019 quarterly 13F filing
| Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price |
|---|---|---|---|---|---|
| Humana (HUM) | 3.7 | $10M | 28k | 366.51 | |
| Hca Holdings (HCA) | 3.4 | $9.2M | 63k | 147.81 | |
| Centene Corporation (CNC) | 3.1 | $8.5M | 135k | 62.87 | |
| Bristol Myers Squibb (BMY) | 3.1 | $8.3M | 130k | 64.19 | |
| Anthem (ELV) | 3.1 | $8.3M | 28k | 302.04 | |
| Tenet Healthcare Corporation (THC) | 3.0 | $8.2M | 215k | 38.03 | |
| Cigna Corp (CI) | 3.0 | $8.2M | 40k | 204.50 | |
| UnitedHealth (UNH) | 3.0 | $8.1M | 28k | 293.96 | |
| Boston Scientific Corporation (BSX) | 2.9 | $7.9M | 175k | 45.22 | |
| Universal Health Services (UHS) | 2.9 | $7.9M | 55k | 143.45 | |
| Danaher Corporation (DHR) | 2.9 | $7.7M | 50k | 153.48 | |
| Sanofi-Aventis SA (SNY) | 2.8 | $7.5M | 150k | 50.20 | |
| Regeneron Pharmaceuticals (REGN) | 2.8 | $7.5M | 20k | 375.50 | |
| Intuitive Surgical (ISRG) | 2.7 | $7.4M | 13k | 591.12 | |
| Vertex Pharmaceuticals Incorporated (VRTX) | 2.6 | $7.1M | 33k | 218.95 | |
| Merck & Co (MRK) | 2.5 | $6.8M | 75k | 90.95 | |
| BioMarin Pharmaceutical (BMRN) | 2.5 | $6.8M | 80k | 84.55 | |
| Eli Lilly & Co. (LLY) | 2.4 | $6.6M | 50k | 131.44 | |
| Grifols S A Sponsored Adr R (GRFS) | 2.4 | $6.4M | 275k | 23.29 | |
| AstraZeneca (AZN) | 2.3 | $6.2M | 125k | 49.86 | |
| Amgen (AMGN) | 2.2 | $6.0M | 25k | 241.08 | |
| Biogen Idec (BIIB) | 2.2 | $5.9M | 20k | 296.75 | |
| Baxter International (BAX) | 2.2 | $5.9M | 70k | 83.61 | |
| Thermo Fisher Scientific (TMO) | 2.1 | $5.7M | 18k | 324.86 | |
| Bio-Rad Laboratories (BIO) | 2.1 | $5.6M | 15k | 370.00 | |
| Iqvia Holdings (IQV) | 2.0 | $5.4M | 35k | 154.51 | |
| Zoetis Inc Cl A (ZTS) | 2.0 | $5.3M | 40k | 132.35 | |
| Stryker Corporation (SYK) | 1.9 | $5.2M | 25k | 209.96 | |
| Zimmer Holdings (ZBH) | 1.9 | $5.2M | 35k | 149.69 | |
| Abbott Laboratories (ABT) | 1.9 | $5.2M | 60k | 86.87 | |
| Johnson & Johnson (JNJ) | 1.9 | $5.1M | 35k | 145.86 | |
| Medtronic (MDT) | 1.9 | $5.1M | 45k | 113.44 | |
| Abbvie (ABBV) | 1.6 | $4.4M | 50k | 88.54 | |
| Laboratory Corp. of America Holdings | 1.6 | $4.2M | 25k | 169.16 | |
| Align Technology (ALGN) | 1.6 | $4.2M | 15k | 279.07 | |
| Smith & Nephew (SNN) | 1.3 | $3.6M | 75k | 48.07 | |
| Incyte Corporation (INCY) | 1.3 | $3.5M | 40k | 87.32 | |
| Edwards Lifesciences (EW) | 1.3 | $3.5M | 15k | 233.27 | |
| Illumina (ILMN) | 1.2 | $3.3M | 10k | 331.70 | |
| Quest Diagnostics Incorporated (DGX) | 1.1 | $2.9M | 28k | 106.80 | |
| Sarepta Therapeutics (SRPT) | 1.1 | $2.9M | 23k | 129.02 | |
| Avantor (AVTR) | 1.0 | $2.7M | 150k | 18.15 | |
| Alcon (ALC) | 0.9 | $2.5M | 45k | 56.58 | |
| Hill-Rom Holdings | 0.8 | $2.3M | 20k | 113.52 | |
| Seattle Genetics | 0.8 | $2.2M | 20k | 114.26 | |
| Bluebird Bio | 0.7 | $1.8M | 20k | 87.75 | |
| Crispr Therapeutics (CRSP) | 0.6 | $1.5M | 25k | 60.92 | |
| Blueprint Medicines (BPMC) | 0.6 | $1.5M | 19k | 80.13 | |
| Sage Therapeutics (SAGE) | 0.4 | $1.1M | 15k | 72.20 | |
| Spdr S&p 500 Etf (SPY) | 0.3 | $825k | 5.0k | 165.00 |
